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A B S T R A C T
The chemical interaction of sodium sulﬁde (Na2S) with the NO-donor S-nitrosoglutathione (GSNO) has
been described to generate new reaction products, including polysulﬁdes and nitrosopersulﬁde (SSNO–)
via intermediacy of thionitrous acid (HSNO). The aim of the present work was to investigate the vascu-
lar effects of the longer-lived products of the Sulﬁde/GSNO interaction. Here we show that the products
of this reaction relax precontracted isolated rings of rat thoracic aorta and mesenteric artery (but to a
lesser degree rat uterus) with a >2-fold potency comparedwith the startingmaterial, GSNO (50 nM), whereas
Na2S and polysulﬁdes have little effect at 1–5 μM. The onset of vasorelaxation of the reaction products
was 7–10 times faster in aorta and mesenteric arteries compared with GSNO. Relaxation to GSNO
(100–500 nM) was blocked by an inhibitor of soluble guanylyl cyclase, ODQ (0.1 and 10 μM), and by the
NO scavenger cPTIO (100 μM), but less affected by prior acidiﬁcation (pH 2–4), and unaffected by
N-acetylcysteine (1 mM) or methemoglobin (20 μM heme). By contrast, relaxation to the Sulﬁde/GSNO
reaction products (100–500 nM based on the starting material) was inhibited to a lesser extent by ODQ,
only slightly decreased by cPTIO, more markedly inhibited by methemoglobin and N-acetylcysteine, and
abolished by acidiﬁcation before addition to the organ bath. The reaction mixture was found to gener-
ate NO as detected by EPR spectroscopy using N-(dithiocarboxy)-N-methyl-D-glucamine (MGD2)-Fe2+ as
spin trap. In conclusion, the Suﬁde/GSNO reaction products are faster and more pronounced vasorelaxants
than GSNO itself. We conclude that in addition to NO formation from SSNO–, reaction products other than
polysulﬁdes may give rise to nitroxyl (HNO) and be involved in the pronounced relaxation induced by
the Sulﬁde/GSNO cross-talk.
© 2014 Elsevier Inc. All rights reserved.
1. Introduction
Endogenously synthesized hydrogen sulﬁde (H2S) is recog-
nized as an important gasotransmitter, which – similar to nitric oxide
(NO) – inﬂuences many different biological processes [1]. Circulat-
ing and intracellular S-nitrosothiols, which are formed by the
interaction of NO with thiol (SH) groups, act as an important bio-
reservoir for NO [2]. Similarly, H2S can be stored in the form of sulfane
sulfur and transported and released in response to a physiological
stimulus [3]. A number of publications reported on the molecular
interaction between H2S and NO or NO-donors [4–14], and H2S and
NO were found to cooperatively regulate vascular tone by activat-
ing a neuroendocrine signaling pathway in which formation of
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nitroxyl (HNO) appears to play an important role [13]. Products of
this H2S/NO interaction appear to have pronounced biological effects;
however the nature of the reaction intermediates is currently unclear
and many inconsistencies remain; for example, H2S donors were
found to either potentiate or attenuate relaxation effect of NO donors
in isolated aortic rings in vitro [15,16], or result in complete loss
of vasodepressor activity in anesthetized rats [16]. H2S was shown
to relax uterus from pregnant [17,18] and non-pregnant rats [19],
and sodium nitroprusside (SNP) prevented H2S induced relax-
ation of rat uterus [20]. Thionitrous acid (HSNO) has been proposed
to represent an important carrier of bioactivity of the interaction
of S-nitrosothiols with H2S [10], but the evidence provided appears
to be inconsistent with the known chemical properties of HSNO.
Moreover, HSNO would be expected to rapidly react with excess
sulﬁde to form other species; thus its biological effect would be very
short-lived. Cortese-Krott and coworkers [12] observed that sulﬁde
reacts with S-nitrosothiols to formmultiple bioactive products, and
proposed that nitrosopersulﬁde (SSNO–; λmax 412 nm in aqueous
buffers, pH 7.4) accounts for some of the longer-lived effects of this
interaction. SSNO– generated both NO and polysulﬁdes on decom-
position, resulting in sustained potentiation of nitrosothiol-
induced soluble guanylate cyclase (sGC) stimulation.While individual
reaction product(s) have not yet been unequivocally identiﬁed it
would appear to be important to further characterize the bioactiv-
ity of key reaction products of the interaction of nitrosothiols and
sulﬁde in intact tissue preparations.
In the present work we followed the procedure of Cortese-
Krott et al. [12] to prepare longer-lived products of the Sulﬁde/
GSNO interaction by pre-incubating sodium sulﬁde (Na2S) with the
NO donor GSNO. Reaction products may include SSNO–, polysul-
ﬁdes and possibly other species [12], but short-lived reaction
intermediates can be safely excluded from contributing to the bio-
activity of the mixture following this route of preparation.
Polysulﬁdes have recently been shown to exert potent biological
effects on a number of targets that may explain, at least in part, some
of the effects of endogenously produced H2S and those observedwith
pharmacological sources of H2S [21–23]. The aim of the present
studies was to evaluate the biological action proﬁle of the reac-
tion products of the Sulﬁde/GSNO interaction in vascular tissue; this
was accomplished by comparing the vasoactive effects of the Sulﬁde/
GSNO products with that of GSNO, Na2S and polysulﬁdes in two
functionally distinct smooth muscle preparations, uterus strips and
rat thoracic aorta (and mesenteric arteries). The former are char-
acterized by phasic spontaneous contractionswith spike-like changes
in membrane potential, while the latter develops tonic contrac-
tions associated with gradual changes in membrane potential when
stimulated by vasoconstrictors [24]. It was shown that rat uterus
is less sensitive to NO than rat aorta; about 10,000-fold less nitro-
prusside (SNP) is required to relax aorta in comparison with rat
uterus [25]. This is consistent with a higher sensitivity to
diethylamine-NO and nitroglycerine in aorta compared with rat
uterus [24].
2. Materials and methods
2.1. Chemicals
All chemicals were purchased from Sigma-Aldrich. Hemoglo-
bin from bovine blood (Sigma H2500), comprising mostly metHb,
was used as received. Na2S•9H2O (Aldrich, 431648) was used as
H2S donor, which dissociates in solution and reacts with H+ to yield
HS−, H2S and a trace of S2− [26]. We use the term ‘sulﬁde’ to en-
compass the total mixture of H2S, HS− and S2−. Na2S•9H2Owaswashed
in distilled H2O and then dissolved in H2O to give a stock solution
of ~100 mM, which was determined by the absorbance (ABS) at
λmax 232 nm, ε = 7700. The concentration of polysulﬁdes in this stock
was <10 μM as judged by UV–VIS spectrophotometry [26]. This stock
solution was always prepared fresh right before the experiment,
kept in sealed vials with minimal headspace and used within 4
hours. The products of the Sulﬁde/GSNO interaction were pre-
pared by mixing equal volumes of 20 mM Na2S with 2 mM GSNO
in 50 mM Tris–HCl buffer, 7.4 pH, at 21 ± 2 °C, resulting in a ﬁnal
pH of 8–9. No qualitative difference in vasorelaxant properties of
the reaction mixture was seen when prepared in more concen-
trated buffer systems according to Cortese-Krott et al. [12]. Product
formation was followed by UV–VIS spectroscopy (absorbance in-
crease at λmax 412 nm), and reaction was complete within 3 min,
by which time the products were diluted to the ﬁnal concentra-
tion in Tris–HCl buffer and added to the organ bath; pH in the organ
bath was kept constant at 7.4. Since SSNO– was proposed to be a
major longer-lived product of the sulﬁde and S-nitrosothiols reac-
tion [12] and no further efforts were made to separate individual
products of the Sulﬁde/GSNO interaction, we hereinafter refer to
the products of the reaction mixture as the ‘SSNO– mix’. The con-
centration of the products is deﬁned as the concentration of GSNO
in the mixture at time zero.
Since for the preparation of the ‘SSNO– mix’, a 10:1 molar excess
of Na2S over GSNO was used, polysulﬁdes were also prepared at a
10:1 sulﬁde/HOCl molar ratio. Polysulﬁdes were prepared by in-
teraction of Na2S with HOCl according to Nagy andWinterbourn [27].
In the experiments with uterus, 500 μl of 5 mM of HOCl (pre-
pared in 100mMNaOH)weremixedwith 500 μl of 50mMof sulﬁde
(prepared from Na2S•9H2O in ultrapure deionized water). To avoid
overoxidation of sulﬁde by HOCl, HOCl was slowly dropped into the
vortexed sulﬁde solution. This system generated 2.5 mM sulfane
sulfur (in the form of inorganic polysulﬁdes, Sn), with the remain-
der being free sulﬁde (~20 mM). The sulﬁde/Sn solution was
immediately applied after the preparation. In the case of experi-
ments with aortic rings, 500 μl of 1 mM of HOCl were mixed with
500 μl of 10 mM of sulﬁde. This system generated 0.5 mM Sn, with
the rest of the sulfur content remaining as free sulﬁde (~4 mM). We
refer to the Sn concentration as the concentration of added HOCl
in the sulﬁde/Sn mixture.
2.2. Measurement of uterus contractility
All protocols for handling rats were approved by the Local Animal
Care Committee of the Institute for Biological Research (Belgrade,
Serbia). Experiments were carried out as previously described [19].
Brieﬂy, virgin female Wistar rats (~225 grams, 10–12 weeks of age)
were used in these experiments. Female rats were staged in their
estrous cycle, as determined by examination of a daily vaginal lavage
[28]. The uterine horns were mounted separately for recording of
isometric tension in De Jalon’s solution containing (in mM): NaCl
154, KCl 5.64, NaHCO3 5.95, CaCl2 0.41 and glucose 2.77, main-
tained at 37 °C and aerated with a gas mixture of 95% oxygen/5%
carbon dioxide. Changes in isometric force were recorded on a TSZ-
04-E Tissue Bath System (Experimetria, Budapest, Hungary). Uteri
were allowed to stabilize during 1 hour, under 1 g initial tension.
Effects of sulﬁde, GSNO, Sn and the ‘SSNO– mix’ were obtained by
adding the respective test agents directly to the organ bath. The
effects of each compound on the area under the curve (AUC) and
frequency were analyzed for ~5 min before and ~5 min after ad-
ministration. If no peaks after the administration were observed,
we evaluated recordings for 5 min after compound addition. The
effect was compared with control values that were measured ~5min
before administration and set as 100%. Results are expressed as
mean ± SEM of n experiments. Normality of the data was tested using
the Shapiro–Wilk test and quantile–quantile plots. Particular sta-
tistical analyses are described in the ﬁgure legends. P values less
than 0.05 were considered to be statistically signiﬁcant.
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2.3. Measurement of rat aorta contractility
All procedures were approved by the State Veterinary and Food
Administration of the Slovak Republic. Experiments were carried
out as previously described [8,9]. Brieﬂy, preparations of thoracic
aorta and arteria mesenterica superior (main branch) were pre-
pared frommaleWistar rats andmounted for recording of isometric
tension changes in oxygenated (95% O2/5% CO2; 37 °C) Krebs-
bicarbonate solution comprising (inmM)118NaCl, 5 KCl, 25NaHCO3,
1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2, 11 glucose, 0.032 CaNa2EDTA, pH
7.5. After equilibration and repeated adjustment of passive tension
rings were precontracted by 1 μM phenylephrine (Phen) to achieve
submaximal contraction; a stable contraction levelwas reached typ-
ically 30–45 min after Phen, which was taken as 100% contraction
(=0% relaxation). The effects of GSNO, sulﬁde, Sn, and the ‘SSNO–mix’
were calculated as% relaxation fromthepre-contraction level. Results
are expressed as mean ± SEM of n experiments. Normality of the
data was tested using the Shapiro–Wilk test and quantile–quantile
plots. Particular statistical analyses aredescribed in theﬁgure legends.
P values less than 0.05were considered to be statistically signiﬁcant.
2.4. EPR measurements
To test whether or not the products of the Sulﬁde–GSNO inter-
action release NO, electron paramagnetic resonance (EPR)
measurements were carried out using N-(dithiocarboxy)-N-methyl-
D-glucamine (MGD)/Fe2+ as a spin trap. The MGD2/Fe2– spin trap
solution (5mMMGD; 1mM FeSO4 in 50mM Tris–HCl buffer, pH 7.4
pH)was prepared freshly right before the experiments [29]. MGD2Fe2+
displays a characteristic three-line EPR spectrum after NO binding.
EPR spectra were measured on a Bruker EMX spectrometer (ﬂat cell,
X-band ~9.4 GHz, central ﬁeld 336 mT, 10-mW microwave power,
0.05 mT modulation amplitude, 0.64 ms time constant, 6 mT scan
range, 40 s scan time) at a temperature of 20 °C. The ‘SSNO– mix’
was directly added to the spin trap solution and EPR spectra were
measured within approx. 3 min.
3. Results and discussion
3.1. Formation and stability of Sulﬁde/GSNO reaction products
Fig. 1A shows the UV-VIS spectral characteristics of the com-
poundsNa2S, GSNO and their reaction products as used in our study.
The spectraof the individual startingmaterials,Na2S andGSNOrapidly
changed immediately aftermixing, and the products revealed a new
absorbance feature at λmax 412 nm (yellow product), we assign to
represent nitrosopersulﬁde (SSNO–) [5,6,12]. A broad absorptionband
at ~260–360 nmwasassigned tobelong toSn, alsoknowntobe formed
in the reaction [12]. After addition of HCl to the product mixture,
which decreased pH from 7.4 to 2–4, the peak at λmax 412 nm dis-
appeared within less than 1 min [11,12]. The spectra are similar to
those in our previous reports using Sulﬁde/GSNO at differentmolar
ratios and using S-nitrosopenicillamine as NO-donor [11,12]. The
sameUV-VIS absorbance featureswere used to study precursor and
product stabilities. GSNO (λmax 334 nm) absorbance did not change
over time, but that of SSNO- (λmax 412 nm)decreased slowly inoxygen/
carbondioxide gassedKrebs-bicarbonate solution to ~80%ofmaximal
absorbance over 20min (Fig. 1B), indicative of its tendency to slowly
decompose in the organ bath solution.
3.2. Effects of sulﬁde, GSNO, Sn and the ‘SSNO– mix’ on uterus
contractility
Sulﬁde (100 and 200 μM) signiﬁcantly decreased AUC and fre-
quency of uterine contraction, whereas GSNO (10 and 20 μM) had
considerably weaker effects (Fig. 2). Interestingly enough, the
products of the reaction mixture (Sulﬁde/GSNO 100/10 μM) were
found to exert only minor effect on both contraction and frequen-
cy; when compared at equimolar concentrationwith regard to sulﬁde
the effects of the reaction products (Sulﬁde/GSNO = 200/20 μM)were
signiﬁcantly lower than with 200 μM sulﬁde alone (Fig. 2B,C). These
results are in accordance with the observation that the NO donor
SNP prevented H2S-induced relaxation of rat uterus, an effect that
was attributed to the generation of nitroxyl (HNO) [20]. Recently,
it was reported that relaxation effects of neutral and anionic forms
of sulﬁde (H2S/HS–) differ in quality and the inhibition of uterine
contractility might be a consequence of the speciﬁc actions of HS–
in relation to its negative charge [19]. Our results of less signiﬁ-
cant effects of the reaction products by comparison with sulﬁde
indicate that the Sulﬁde/GSNO interaction diminishes the relax-
ing effects of sulﬁde, even at a Sulﬁde/GSNO molar ratio of 10/1.
Since the ﬁrst application of sulﬁde on uterus strips had less re-
laxation effect than the second and third application (Fig. 2D), we
compared effects of sulﬁde and Sn at these subsequent applica-
tions. There was no signiﬁcant difference between the relaxation
effect of sulﬁde in the presence and absence of Sn applied as the
ﬁrst or third addition (Fig. 2D). In summary, sulﬁde exerts power-
ful inhibitory effects on uterine smooth muscle, which appear to
Fig. 1. (A) The UV-VIS absorption spectra of 1mMNa2S (dotted), 0.1mMGSNO (dash-
dotted), the mixture of Na2S and GSNO after 3 min incubation (the ‘SSNO– mix’; full)
and after addition of HCl to decrease pH from 7.4 to 2–4 (dashed line). Buffer: 50mM
Tris–HCl, pH 7.4. ABS – absorbance. (B) Time-dependent changes in absorbance of
GSNO (λmax 334 nm; 100 μM, circles-full line) and the Sulﬁde/GSNO product, SSNO–
(λmax 412 nm, 100 μM, triangles-dash line) in O2/CO2 bubbled Krebs-bicarbonate buffer
(n = 3).
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be unaffected by the presence of Sn but are diminished by interac-
tion with NO-donors such as nitrosothiols. These ﬁndings suggest
that Sn play less prominent roles in relaxing uterine tissue com-
pared with sulﬁde alone, and that the interaction of sulﬁde with
NO attenuates sulﬁde’s inhibitory action. Considering that sulﬁde
may be produced from cystathionine-γ-lyase (CSE) in utero NOmight
be expected to play a suppressor role by modulating sulﬁde’s action
on uterus contraction [30].
To evaluate whether the results observed in uterus strips are rep-
resentative of smooth muscle in general, we used two different
vascular preparations in the next part of our investigation. Since
aortic smooth muscles are functionally distinct and more sensi-
tive to NO than uterine muscles [25], we compared the effects of
sulﬁde, Sn, GSNO and the ‘SSNO– mix’ on rat aortic strips.
3.3. Effects of sulﬁde, GSNO, Sn and the ‘SSNO– mix’ on aortic
contractility
An example of the relaxing effects of GSNO and the ‘SSNO– mix’
in phenylephrine (1 μM) precontracted rat aortic ring is shown in
Fig. 3A and B. The relaxation effect of the ‘SSNO– mix’ was signiﬁ-
cantly pronounced, faster and shorter lasting when compared with
GSNO in both, aortic and mesenteric rings (Fig. 3). The relaxation
effect of the ‘SSNO– mix’ (50 nM) onmesenteric artery was 2.6 times
more powerful than that of GSNO (50 nM) (Fig. 4g,p). The time re-
quired for relaxation to return to 50% of its maximal effect was
5.5 ± 0.5 min and >10min for the ‘SSNO– mix’ compared with GSNO
itself (100 nM). Since ~90% of SSNO– was still present in the bath
solution during the decay phase (Figs 3A, 5A,B), wemay assume that
a product(s) within the ‘SSNO– mix’ other than NOmust be respon-
sible for the tachyphylaxis to the initial vasorelaxation observed.
A similar reversal of the relaxation has been reported for other com-
pounds (including nitroglycerine, mastoparan and exogenous NO)
and suggested to involve different pathways in addition to sGC de-
sensitization [31–34]. The relaxation was ﬁtted by a simple
exponential decay function, F = y0+a*exp(-b*x) (Fig. 3C). The speed
of relaxation triggered by the ‘SSNO– mix’ (50 nM) was 7.0 and 10.7
times faster for rat thoracic aorta and mesentericum, respectively,
when compared with GSNO (50 nM). The average absolute values
of τ1/2 for the induced relaxation by the ‘SSNO– mix’ and GSNO
(50 nM)were 13 and 91 s, respectively (Fig. 3D). These half-lives rep-
resent considerably faster reactions than the measured
decomposition rates for either SSNO– in the ‘SSNO– mix’ (λmax
412 nm) or GSNO (λmax 334 nm) in gassed Krebs-bicarbonate buffer
(Fig. 1B). The divergence between the rates of decomposition and
speed of relaxation (compare Figs 1B, 3 and 5C) suggests the in-
volvement of an unknown enzymatic/non-enzymatic component
within the vasculature that promotes NO release from GSNO and
its reaction products with sulﬁde in situ; however, we cannot exclude
at this juncture that a reaction product other than NO (e.g. SSNO–,
HNO) directly triggers vasorelaxation. The surprisingly good ﬁt of
the time-dependent relaxation of the reaction products by the simple
exponential decay function (Figs 3C and 5C), however, suggests an
interaction of a single component of the ‘SSNO–mix’ with (a) target(s)
in vascular smooth muscle.
Thus, sulﬁde and GSNO have different effects on uterine and vas-
cular smooth muscle, and either action appears to be different to
that of the reaction products of the Sulﬁde/GSNO interaction (Figs 2,
3). The mechanisms of contraction and relaxation between uterus
and aorta differ. It was reported that SNP prevented H2S induced
relaxation of rat uterus, and this effect was attributed to the gen-
eration of nitroxyl (HNO) [20]. From the different sensitivities of rat
uterus and aorta to NO [25], it was suggested that an activation of
sGC, a key mechanism for vasorelaxation in many non-uterine
smooth muscle such as aortic tissue, may not be involved in uterine
relaxation [35]. The results of the present study suggest that the
products of the Sulﬁde/GSNO interactionmay play an important role
in muscle in which activation of sGC is involved in regulating their
tonicity.
Fig. 2. Effect of sulﬁde, GSNO, the ‘SSNO– mix’ and Sn on uterine contractility. Rep-
resentative isometric recordings of calcium contracted rat uterine strips; comparison
of the effects of sulﬁde (200 μM), the ‘SSNO– mix’ (Sulﬁde/GSNO 200/20 μM) and
again sulﬁde (200 μM) (A). Effects of sulﬁde (100 and 200 μM, black), GSNO (10 and
20 μM, white) and the ‘SSNO– mix’ (Sulﬁde/GSNO 100/10 and 200/20 μM, gray) on
the area under the curve (AUC) (B) and frequency (C). Effects of three consequent
additions of sulﬁde (D, a, b, c, 100 μM) alone, and comparison of sulﬁde (d, 100 μM)
with sulﬁde/Sn (e, 100/12.5 μM) at the ﬁrst addition and sulﬁde/Sn (f, 100/12.5 μM)
with sulﬁde (g, 100 μM) at the third addition. The values represent decrease of the
parameters to given % versus 100% of control. Nonparametric Skillings–Mack’s sta-
tistical test, followed by the Dwass–Steel–Chritchlow–Fligner’s test was used to
compare effects of sulﬁde, GSNO and the ‘SSNO– mix’ versus control (B, C), *P < 0.05,
**P < 0.01; effects of the ‘SSNO– mix’ (10 μM) and GSNO (10 μM) versus sulﬁde
(100 μM) (B, C), #P < 0.05; and effects of the ‘SSNO– mix’ (20 μM) and GSNO (20 μM)
versus sulﬁde (200 μM) (B, C), †P < 0.05. Friedman’s statistical test, followed by
Conover’s test was used to compare effects of subsequent sulﬁde additions versus
control (D), *P < 0.05, **P < 0.01. Wilcoxon’s test was used to compare effects of sulﬁde
(100 μM) versus sulﬁde/Sn (12.5 μM) (D).
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In order to investigate the possible involvement of sulﬁde or Sn
in the relaxation effects of the ‘SSNO– mix’, a sulﬁde/Sn mixturemim-
icking the concentrations in the SSNO– containing reaction solution
was prepared. Sulﬁde and sulﬁde/Sn (1, 2 and 5 μM of the original
Na2S concentration) had minor non-signiﬁcant effects on vascular
tone in aortic rings (Fig. 4), demonstrating that neither the excess
sulﬁde nor the oxidation products can account for the pronounced
relaxation induced by the products of the Sulﬁde/GSNO interac-
tion. Our ﬁndings are in agreement with other reports showing that
low μM concentrations of sulﬁde neither relax pre-constrictedmouse
aortic strips [36] nor human lobar pulmonary arteries [37].
sGC is a key enzyme of the NO signaling pathway. On binding
of NO to the prosthetic heme group on sGC, the enzyme catalyzes
the synthesis of the second messenger cGMP which induces
vasorelaxation [38]. To conﬁrm the suspected involvement of the
NO/sGC signaling pathway in the relaxation effect of the ‘SSNO– mix’,
the sGC inhibitor ODQ was applied 15 min before addition of the
contractile agonist. The effects of GSNO and the ‘SSNO– mix’ were
compared in the absence and presence of ODQ at 10 μM and 100 nM
concentrations. Vasorelaxation of GSNO and the ‘SSNO– mix’
(100–500 nM) was virtually eliminated by 10 μM ODQ, conﬁrm-
ing the involvement of the sGC signaling pathway mediating
relaxation (data not shown). Much lower concentrations of ODQ
(100 nM) inhibited the relaxation of equipotent concentrations of
GSNO (1 μM) and the ‘SSNO–mix’ (100 nM) to a similar extent (Fig. 4).
These results indicate that the active component(s) of the Sulﬁde–
GSNO interaction is/are membrane-permeable and may release NO
more eﬃciently than GSNO; alternatively, the reaction products may
have a higher aﬃnity for sGC without releasing free NO.
3.4. Modulation of the relaxation effect of the ‘SSNO– mix’ and GSNO
To evaluate the importance of NO in the observed relaxation
effects (Figs 3 and 4), the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) was applied [39].
cPTIO (100 μM) alone had no effect on basal vascular tone, but sig-
niﬁcantly increased contraction in the presence of phenylephrine
(Fig. 5A and B). These effects are identical to those of the NO-
scavenger oxyhemoglobin, which increases vascular contractile tone
only following agonist-induced precontraction [40] and consis-
tent with the notion that endothelial NO synthase activity is
upregulated in the presence of contractile agonists. The level of
maximal contraction achieved with cPTIO was comparable with that
of the NOS-inhibitor, L-nitro-L-arginine (not shown); thus, the ad-
ditional contraction observed upon addition of cPTIO is due to the
scavenging of basal NO release from the endothelium. Although
cPTIO is membrane-impermeable [41,42] its eﬃciency as an extra-
cellular NO oxidant provides a large enough sink for NO to interfere
with vascular tone.
The relaxation effect of GSNO (100 nM) was effectively inhib-
ited by excess cPTIO (100 μM; Fig. 5), indicating that GSNO acts
almost exclusively via releasing NO. On the contrary, relaxation
induced by the ‘SSNO– mix’ (100 nM) was not inhibited by the
presence of cPTIO, regardless of whether it was added before or
after Phen (Fig. 5). These results indicate that a signiﬁcant portion
of the relaxation induced by these reaction products is mediated
by an alternative mechanism, which may directly activate sGC
without releasing free NO. These effects of cPTIO and ODQ on the
products of the Sulﬁde/GSNO interaction are reminiscent of reports
on effects of the HNO donor Angeli’s salt (AS) [43–45]. This sug-
gests that HNO may be involved in the relaxation effects induced
by the ‘SSNO– mix’. Similar to other HNO donors, AS is known to
induce vasorelaxation in an NO/sGC-dependent fashion following
oxidation [46,47].
It was reported that in the presence of N-acetylcysteine (NAC),
the thiol reacts with HNO, thereby reducing the relaxation effect
of HNO on precontracted rat aorta [48]. Hemoproteins are known
to react with HNO to generate the corresponding nitrosyl adducts
[49]. To test the assumption that vasorelaxation of the ‘SSNO– mix’
is, at least in part, mediated by the release of nitroxyl additional
experiments were carried out with the HNO scavengers, methe-
moglobin (20 μM heme) and (NAC, 1 mM) [47]. The vasodilator
effects of GSNO were not signiﬁcantly inﬂuenced by NAC, but re-
laxation to the ‘SSNO– mix’ was signiﬁcantly attenuated by NAC
(Fig. 5D). Whereas the relaxation effects of GSNO was not signiﬁ-
cantly inﬂuenced by metHb (which is a very ineﬃcient NO
scavenger), that of the SSNO- mix’ was partially inhibited (Fig. 5).
Fig. 3. Representative time-dependent relaxation effects of GSNO (100 nM), the ‘SSNO–
mix’ (100 nM) and sulﬁde (1 μM) on phenylephrine (Phen) precontracted rat aortic
rings (A, B, C). H denotes height (=extent of relaxation) whereasW indicates the width,
i.e. the time required for relaxation to return to 50% of the maximum. Time-
dependent relaxation ﬁtted the simple exponential decay function, F = y0 +
a*exp(-b*x), for the ‘SSNO– mix’ (experiment – full, ﬁt – dotted) and for GSNO (ex-
periment – dash, ﬁt – dotted) (sulﬁde at 1 μM had not effect) (C). The time to reach
50% of relaxation (τ1/2) by GSNO (open bars) and (gray bars) at 50 and 100 nM in
aorta and in mesenteric rings at 50 nM (coarse) (D). **P < 0.01 indicates compari-
son of the effect of the ‘SSNO– mix’ versus GSNO (unpaired t test).
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Our results are consistent with the view that a component of the
products of the Sulﬁde/GSNO interaction is capable of releasing
HNO.
Since acidiﬁcation of the reaction mixture caused rapid decom-
position of SSNO– (Fig. 1A [11,12];), the effect of such a pH adjustment
on vasorelaxation was studied in isolated aortic rings. The relax-
ation effect of the Sulﬁde/GSNO products vanished when HCl was
added to the reaction mixture before application to the organ bath.
By contrast, the relaxation effect of GSNO was only slightly affect-
ed by acidiﬁcation (Fig. 5). Taken together, these results clearly
demonstrate that the reaction product with an absorptionmaximum
at 412 nm (assigned by us as nitrosopersulﬁde) accounts for the ma-
jority of the pronounced and fast relaxation effects of the Sulﬁde–
GSNO interaction in aortic rings.
3.5. EPR spectra of MGD2Fe2+ spin trap with the Sulﬁde/GSNO
products
Since a key reaction product of the interaction of sulﬁde with
nitrosothiols, SSNO– has been shown previously to release NO as
measured by gas phase chemiluminescence and to activate sGC in
cellular systems [12], it was of interest to conﬁrm that NO can indeed
be generated from longer-lived reaction products (the ‘SSNO– mix’)
using a complementary detection technique. In the present study
we chose electron paramagnetic resonance spectroscopy using
MGD2Fe2+ as spin trap. The reagent itself does not have an EPR spec-
trum (Fig. 6A). After addition of the Sulﬁde/GSNO reaction mixture
to the spin trap a superposition of two different EPR spectra was
observed (Fig. 6B). The spectral intensity slowly decreased over time
(to ~60% in 20 min, data not shown). In parallel experiments with
GSNO, a stable simple triplet spectrumwas detected (Fig. 6C), which
could be clearly assigned to NO trapped by MGD2Fe2+ heme [29].
By comparison of the double integrals of the spectra B and C, the
concentration of MGD2Fe2+-radical complex in the Sulﬁde/GSNO
product mixture (B) corresponded to about 10% of GSNO (D). After
subtraction of spectrum C from B, a single triplet spectrumwas ob-
served (Fig. 6D) with slightly different EPR parameters compared
with spectrum C. From the simulated spectra C (MGD2Fe2+-NO) and
D the following spectral parameters were obtained: the isotropic
splitting constant aN = 1.26mT and aN = 1.19mT and g-factor g = 2.040
and g = 2.037, respectively. The lower aN parameter for the spec-
trum D versus C indicates that a density of the unpaired electron
of the nitrogen nucleus in D was less than in spectrum C. The dif-
ferences in g-factor values between spectra C and D indicate a
different coordination of NO and an NO-containing unknown adduct
to theMGD2Fe2+ spin trap. However, when sulﬁdewas added to spin-
trapped NO from GSNO (spectrum C), a superposition of two EPR
spectra was observed (E), similar to the features of spectrum B. This
indicates that sulﬁde, alone or in combination with NO or the ‘SSNO–
mix’, can inﬂuence the structure of the spin trap adduct. Since the
NO scavenger cPTIO inhibited the vasorelaxation of GSNO but not
that of the ‘SSNO– mix’ (Fig. 5), we suggest that an NO-containing
component(s) of the Sulﬁde/GSNO reaction may bind to a pros-
thetic heme on sGC, resulting in enzyme activation and consecutive
vasorelaxation and/or release of NO following its binding to heme.
3.6. Conclusions
The products of the interaction of sulﬁde with GSNO, em-
ployed in the present study as a model nitrosothiol of potential
(patho)physiological signiﬁcance, was found to exert more pro-
nounced and faster relaxation effects in precontracted aortic rings
than the parent compound GSNO. While GSNO and the product(s)
of its chemical interaction with sulﬁde both act via stimulation of
sGC, their relaxation proﬁles were differentially modulated by cPTIO,
metHb and N-acetylcysteine, and acidiﬁcation. This strongly sug-
gests the involvement of more than one product (in the reaction
mixture) accounting for sGC activation and vasorelaxation. While
NO is clearly involved in the mechanism of relaxation, HNO appears
to be another reactive intermediate. Our results cannot exclude the
possibility of a direct sGC activation via an alternative mecha-
nism. Since the products of the Sulﬁde/GSNO interaction were
applied 3 min after mixing (i.e. at a time when no further absor-
bance changes were seen) relatively long-lived reaction product(s)
Fig. 4. Relaxation effect of sulﬁde (a = 1, b = 2, c = 5 μM, black), sulﬁde/Sn (d = 0.8/0.1, e = 1.6/0.2, f = 4/0.5 μM, vertical coarse), GSNO (g = 0.05, h = 0.1, i = 0.2, j = 0.5, k = 1 μM,
white), GSNO in the presence of 100 nM ODQ (l = 0.1, m = 0.2, n = 0.5, o = 1 μM, coarse), the ‘SSNO– mix’ (p = 0.05, r = 0.1, s = 0.2, t = 0.5 μM, gray) and the ‘SSNO– mix’ in the
presence of 100 nM ODQ (u = 0.1, v = 0.2, w = 0.5 μM, gray-coarse). Effect of the ‘SSNO– mix’ versus GSNO at 0.05, 0.1, 0.2 and 0.5 μM was determined using an unbalanced,
two-way ANOVA with post-hoc Tukey’s HSD test. There was signiﬁcant effect of the concentration (F = 34.12, P ANOVA < 0.0001) and treatment (F = 103.12, P ANOVA < 0.0001),
but not the interaction concentration*treatment (F = 0.70, P ANOVA = 0.55); *P < 0.05; **P < 0.01. Effect of the ‘SSNO– mix’ versus GSNO at 0.1, 0.2 and 0.5 μM pretreated with
0.1 μMODQwas determined using an unbalanced, two-way ANOVAwith post-hoc Tukey’s HSD test. There was signiﬁcant effect of the concentration (F = 6.90, P ANOVA < 0.0033)
and treatment (F = 33.60, P ANOVA < 0.0001), as well as the interaction concentration*treatment (F = 5.85, P ANOVA = 0.007); ##P < 0.01. Effect of GSNO at 0.1, 0.2, 0.5 and
1 μM pretreated with 0.1 μM ODQ versus GSNO was determined using an unbalanced, two-way ANOVA with post-hoc Tukey’s HSD test. There was signiﬁcant effect of the
treatment (F = 124.58, P ANOVA < 0.0001) but not the concentration (F = 3.23, P ANOVA < 0.051). The interaction concentration*treatment was not signiﬁcant (F = 2.54, P
ANOVA < 0.093); ††P < 0.01. Effect of the ‘SSNO– mix’ at 0.1, 0.2 and 0.5 μM pretreated with 0.1 μM ODQ versus the ‘SSNO– mix’ was determined using the unbalanced, two-
way ANOVA with post-hoc Tukey’s HSD test. There was signiﬁcant effect of the treatment (F = 175.70, P ANOVA < 0.0001) and the concentration (F = 7.60, P ANOVA < 0.0019).
The interaction concentration*treatment was not signiﬁcant (F = 0.80, P ANOVA < 0.45). ααP < 0.01. Effect of sulﬁde 1, 2 and 5 μM versus 0.5 μM GSNO was determined using
Dunnett multiple comparison; ββP < 0.01. Effect of sulﬁde 1, 2 and 5 μM versus 0.5 μM the ‘SSNO– mix’ was determined using the Dunnett multiple comparison; λλP < 0.01.
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must account for the relaxation observed. These may include Sn and
SSNO– [12,13,50]. Using EPR spectroscopy we conﬁrmed the release
of NO from the reaction mixture, but SSNO– is not known to release
HNO. Since sulﬁde and Sn, at the concentrations expected to prevail
in the reaction mixture, did not induce vasorelaxation under com-
parable conditions, SSNO– and a yet uncharacterized product capable
of generating HNO appear to account for the pronounced relax-
ation effects of the ‘SSNO– mix’. Whether any of this chemistry
contributes to the biological cross-talk between sulﬁde and NO in
the cardiovascular system warrants further investigation.
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Fig. 5. Representative time-dependent contractile effect of cPTIO (100 μM), fol-
lowed by relaxation to the ‘SSNO– mix’ and GSNO (both at 100 nM) in phenylephrine
(Phen) precontracted rat aortic rings (A, B). Direct comparison of the time course
of relaxation for the ‘SSNO– mix’ and GSNO (both at 100 nM) (C). (D) Comparison
of the relaxation effect of GSNO (100 nM) alone (a, white), when pH of GSNO so-
lution was decreased to 2–4 by HCl before application (b, white, coarse), GSNO in
the presence of cPTIO (c, 100 μM, white, ﬁne coarse) or NAC (d, 1 mM, white, cross-
coarse). Relaxation effect of GSNO in the absence (e, 200 nM, white) and presence
of methemoglobin (f, 20 μM heme, white, horizontal coarse). Comparison of the re-
laxation effect of the ‘SSNO– mix’ (100 nM) alone (g, gray), after adjustment of the
pH to 2–4 by HCl before application (h, gray, coarse), and the ‘SSNO– mix’ in the pres-
ence of cPTIO (i, 100 μM, gray, ﬁne coarse) or NAC (j, 1 mM, gray, cross-coarse).
Comparison of the relaxation effect of the ‘SSNO– mix’ (200 nM) alone (k, gray) and
in the presence of methemoglobin (l, 20 μM heme, gray, horizontal coarse). Effect
of HCl, cPTIO and NAC versus 100 nM GSNO was analyzed using the Kruskal–
Wallis test followed by theMann–WhitneyU test with Bonferroni correction; *P < 0.05;
**P < 0.01. Effect of hemoglobin versus 200 nM GSNO was analyzed using a single
Mann–Whitney U test. Effect of HCl, cPTIO and NAC versus 100 nM the ‘SSNO– mix’
was analyzed using the Kruskal–Wallis test followed by the Mann–Whitney U test
with Bonferroni correction; #P < 0.05; ##P < 0.01. Effect of hemoglobin versus 200 nM
‘SSNO– mix’ was analyzed using a single Mann–Whitney U test; ††P < 0.01.
Fig. 6. EPR spectra of spin trap MGD2Fe2+ (5 mM MGD, 1 mM FeSO4) alone (A) and
in the presence of the ‘SSNO– mix’ (B, 0.5 mM), GSNO (C, 0.5 mM) and substracted
spectra B–C (D). EPR spectra in the presence of GSNO (0.5mM) after addition of 5mM
sulﬁde (E). The spectra were normalized to similar intensity.
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